HYPR icon

Hyperfine

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 91.7%
Negative

Neutral
Business Wire
4 days ago
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
GUILFORD, Conn.--(BUSINESS WIRE)--Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
Neutral
Business Wire
7 days ago
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Preliminary, Unaudited Financial Results Preliminary, unaudited revenue for the fourth qua.
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Neutral
Business Wire
13 days ago
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces the first analysis showing the AI-powered Swoop® portable MRI system reduces hospital costs and improves economics in acute care.
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
Neutral
Business Wire
1 month ago
Hyperfine Announces Regulatory Approval of the Swoop® System in India
GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.
Hyperfine Announces Regulatory Approval of the Swoop® System in India
Neutral
Business Wire
1 month ago
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
Neutral
Business Wire
1 month ago
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
Neutral
Business Wire
2 months ago
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
Neutral
Seeking Alpha
2 months ago
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Hyperfine, Inc. ( HYPR ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Webb Campbell Maria Sainz - CEO, President & Director Brett Hale - Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Conference Call Participants Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to Hyperfine's Third Quarter 2025 Earnings Conference Call.
Hyperfine, Inc. (HYPR) Q3 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 months ago
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.14 per share a year ago.
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates
Neutral
Business Wire
2 months ago
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine today announced third quarter 2025 financial results and provided a business update.
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results